TWM572746U - A coated structure for preventing glutathione oxidation - Google Patents
A coated structure for preventing glutathione oxidation Download PDFInfo
- Publication number
- TWM572746U TWM572746U TW107211678U TW107211678U TWM572746U TW M572746 U TWM572746 U TW M572746U TW 107211678 U TW107211678 U TW 107211678U TW 107211678 U TW107211678 U TW 107211678U TW M572746 U TWM572746 U TW M572746U
- Authority
- TW
- Taiwan
- Prior art keywords
- glutathione
- layer
- oxidation
- powder
- coated
- Prior art date
Links
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 title claims abstract description 98
- 229960003180 glutathione Drugs 0.000 title claims abstract description 48
- 108010024636 Glutathione Proteins 0.000 title claims abstract description 45
- 230000003647 oxidation Effects 0.000 title claims abstract description 18
- 238000007254 oxidation reaction Methods 0.000 title claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 18
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 14
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 abstract description 8
- 239000003963 antioxidant agent Substances 0.000 abstract description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 239000002253 acid Substances 0.000 abstract description 3
- 239000007864 aqueous solution Substances 0.000 abstract description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 2
- 239000003833 bile salt Substances 0.000 abstract description 2
- 229940093761 bile salts Drugs 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 229960001231 choline Drugs 0.000 abstract description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 239000012530 fluid Substances 0.000 abstract description 2
- 210000004211 gastric acid Anatomy 0.000 abstract description 2
- 230000000968 intestinal effect Effects 0.000 abstract description 2
- 229910052760 oxygen Inorganic materials 0.000 abstract description 2
- 239000001301 oxygen Substances 0.000 abstract description 2
- 210000000936 intestine Anatomy 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000005445 natural material Substances 0.000 abstract 1
- 230000036542 oxidative stress Effects 0.000 abstract 1
- 239000003925 fat Substances 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
- 235000018417 cysteine Nutrition 0.000 description 5
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 5
- 108010053070 Glutathione Disulfide Proteins 0.000 description 4
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 3
- 229930195712 glutamate Natural products 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108010081687 Glutamate-cysteine ligase Proteins 0.000 description 1
- 102100039696 Glutamate-cysteine ligase catalytic subunit Human genes 0.000 description 1
- 108010063907 Glutathione Reductase Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 1
- 108010036164 Glutathione synthase Proteins 0.000 description 1
- 102100034294 Glutathione synthetase Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229940045883 glutathione disulfide Drugs 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
穀胱甘肽是一著名的抗氧化天然物，可協助細胞將自由基捕捉，以避免細胞內主要分子受到氧化壓力作用破壞，而造成相關疾病。本創作係關於一種用於包埋穀胱甘肽防止氧化之多層包埋結構，包含一穀胱甘肽粉狀核芯、一脂肪層、一蛋白質層與一防水層。該粉狀核芯是由穀胱甘肽粉末組成，在腸道釋放吸收後進入血液，輸送至全身細胞，可以加強細胞抗氧化功效。該脂肪層於穀胱甘肽粉末核芯表面，讓穀胱甘肽與空氣隔絕，以防止穀胱甘肽氧化，並保護該粉末在腸道才溶解分散，並具備抗胃酸與腸道膽鹼之效果。該蛋白質層是包覆固定於脂肪層外表面，具備競爭活性氧之功用，可保護穀胱甘肽不被氧化。該防水層是包覆固定於蛋白質層外表面，使包埋劑體在水溶液中不易分散，不受胃酸與膽鹽之破壞。透過該防止穀胱甘肽氧化的層狀結構設計，可使包覆之穀胱甘肽粉末在腸道釋出吸收，在腸道吸收後，進入組織液與血液中，輸送至全身細胞加強細胞抗氧化功能。 Glutathione is a well-known antioxidant natural substance that helps cells capture free radicals to prevent major molecules in the cell from being destroyed by oxidative stress, causing related diseases. The present invention relates to a multilayer embedding structure for embedding glutathione to prevent oxidation, comprising a glutathione powder core, a fat layer, a protein layer and a waterproof layer. The powdery core is composed of glutathione powder, which is released into the blood after being released into the intestine and transported to the whole body cells, thereby enhancing the antioxidant effect of the cells. The fat layer is on the surface of the glutathione powder core, which separates glutathione from the air to prevent oxidation of glutathione, protects the powder from dissolving and dispersing in the intestine, and has anti-gastric acid and intestinal choline. The effect. The protein layer is coated and fixed on the outer surface of the fat layer and has the function of competing active oxygen to protect the glutathione from oxidation. The waterproof layer is coated and fixed on the outer surface of the protein layer, so that the embedding agent is not easily dispersed in the aqueous solution and is not damaged by gastric acid and bile salts. Through the layered structure design of preventing glutathione oxidation, the coated glutathione powder can be released and absorbed in the intestinal tract, and after absorption in the intestinal tract, it enters the tissue fluid and blood, and is transported to the whole body cell to strengthen the cell resistance. Oxidation function.
Description
本創作係關於一種防止穀胱甘肽氧化之包埋結構的技術領域。 This work is about the technical field of an embedded structure for preventing oxidation of glutathione.
穀胱甘肽(glutathione，GSH)又稱為麩氨基硫(英文縮寫為GSH)，分子量為307g/mol，由穀胺酸(或稱麩胺酸，glutamate)、半胱胺酸(cysteine)及甘胺酸(glycine)三種胺基酸所組成的小分子胜肽(三肽)，也是一種硫醇類。一般高濃度的存在於真核生物的細胞內，是細胞內含量最豐富的抗氧化劑。但細胞受到老化、受傷等因素，含量會逐漸降低，因而無法有效保護細胞不受自由基或各式氧化物質之危害。適當的補充，可以強化細胞抗氧化能力。 Glutathione (GSH), also known as glutathione (GSH), has a molecular weight of 307 g/mol, consisting of glutamic acid (glutamate), cysteine (cysteine) and A small molecule peptide (tripeptide) composed of three amino acids of glycine is also a thiol. Generally present in high concentrations of cells in eukaryotes, it is the most abundant antioxidant in the cell. However, the cells are subject to aging, injury and other factors, and the content will gradually decrease, thus failing to effectively protect the cells from free radicals or various oxidizing substances. Appropriate supplementation can strengthen the cell's antioxidant capacity.
穀胱甘肽在體內會存在兩種形式，一種為還原型(GSH)，具備抗氧化能力。當還原型吸收自由基或被氧化物質作用後，會產生雙硫鍵形成雙體的氧化型結構(glutathione disulfide，GSSG)，其中氧化型穀胱甘肽在NADPH輔酶參與下，會被被穀胱甘肽還原酶(glutathione reductase，GSH-Rx)還原成GSH，可重複使用；而氧化型則是穀胱甘肽通過穀胱甘肽過氧化物酶(Glutathione peroxidase，GSH-Px)或氧化物質而被氧化成GSSG。 Glutathione exists in two forms in the body, one is reduced (GSH) and has antioxidant capacity. When the reduced type absorbs free radicals or acts as an oxidized species, it produces a disulfide bond to form a double-body glutathione disulfide (GSSG). The oxidized glutathione is involved in the glutathione with the participation of NADPH coenzyme. Glutathione reductase (GSH-Rx) is reduced to GSH and can be reused; while oxidized form is glutathione by Glutathione peroxidase (GSH-Px) or oxidizing substances. It is oxidized to GSSG.
兩種類型穀胱甘肽同時存在體內，構成一動態平衡維持一定 的量，且互相轉換，構成一有效的抗氧化系統，其中還原型穀胱甘肽比例較高，約占90%。 Both types of glutathione are present in the body, forming a dynamic balance to maintain a certain The amount, and mutual conversion, constitutes an effective antioxidant system, in which the proportion of reduced glutathione is relatively high, accounting for about 90%.
部分細菌可以生合成穀胱甘肽，而大部分的哺乳動物、植物細胞也都可以自我合成。穀胱甘肽是由穀胺酸、半胱胺酸及甘胺酸三種胺基酸所組成的小分子胜肽或硫醇類。 Some bacteria can produce glutathione, and most mammals and plant cells can also synthesize themselves. Glutathione is a small molecule peptide or thiol composed of three amino acids, glutamic acid, cysteine and glycine.
細胞合成穀胱甘肽是經兩個ATP能量提供分子參與的步驟。首先穀胺酸和半胱胺酸經由酵素接合，該酵素為丙-穀胺酸基半胱胺酸合成酶(γ-glutamylcysteine synthetase)，或稱穀胺酸與半胱胺酸接合酶(glutamate cysteine ligase，GCL)，接下來甘胺酸再被穀胱甘肽合成酶(glutathione synthetase)接上第一步驟所合成的雙肽，因而合成穀胱甘肽。 Cell synthesis of glutathione is a step involved by two ATP energy providing molecules. First, glutamate and cysteine are joined by an enzyme called gamma-glutamylcysteine synthetase, or glutamate cysteine. Ligase, GCL), followed by glycine acid glutathione synthetase followed by the dipeptide synthesized in the first step, thus synthesizing glutathione.
穀胱甘肽已知是細胞內重要的抗氧化成分，保護細胞內重要分子不受自由基傷害，包括核酸、蛋白質、脂質等，以維持細胞正常功能的運作。 Glutathione is known to be an important antioxidant in the cell, protecting important molecules in cells from free radical damage, including nucleic acids, proteins, lipids, etc., in order to maintain the normal functioning of cells.
本創作係關於一種防止穀胱甘肽氧化之包埋結構的技術領域。 This work is about the technical field of an embedded structure for preventing oxidation of glutathione.
本創作係關於一種用於包埋穀胱甘肽防止氧化之多層包埋結構，包含一穀胱甘肽粉末核芯、一脂肪層、一蛋白質層與一防水層。 The present invention relates to a multilayer embedding structure for embedding glutathione to prevent oxidation, comprising a glutathione powder core, a fat layer, a protein layer and a waterproof layer.
該核芯由具抗氧化功效的穀胱甘肽粉末組成，在腸道吸收後，經由血液運輸至全身細胞，提供細胞保護作用。 The core is composed of an antioxidant powder glutathione powder, which is transported to the whole body cells via the blood after absorption in the intestinal tract to provide cytoprotection.
該脂肪層是包覆固定於於穀胱甘肽粉末核芯表面，讓穀胱甘肽與空氣隔絕，以防止穀胱甘肽氧化，並保護該粉末在腸道才溶解分散，並 具備抗胃酸與腸道膽鹼之效果。該蛋白質層是包覆固定於脂肪層外表面，具備競爭活性氧之功用，可保護穀胱甘肽不被氧化。該防水層是包覆固定於蛋白質層外表面，使包埋劑體在水溶液中不易分散，不受胃酸與膽鹽之破壞。 The fat layer is coated and fixed on the surface of the glutathione powder core to isolate glutathione from air to prevent oxidation of glutathione and protect the powder from dissolving and dispersing in the intestinal tract. It has anti-gastric acid and intestinal choline effects. The protein layer is coated and fixed on the outer surface of the fat layer and has the function of competing active oxygen to protect the glutathione from oxidation. The waterproof layer is coated and fixed on the outer surface of the protein layer, so that the embedding agent is not easily dispersed in the aqueous solution and is not damaged by gastric acid and bile salts.
透過該防止穀胱甘肽氧化的層狀結構設計，可使包覆之穀胱甘肽粉末在腸道釋出吸收，在腸道吸收後，進入組織液與血液中，輸送至全身細胞加強細胞抗氧化功能。 Through the layered structure design of preventing glutathione oxidation, the coated glutathione powder can be released and absorbed in the intestinal tract, and after absorption in the intestinal tract, it enters the tissue fluid and blood, and is transported to the whole body cell to strengthen the cell resistance. Oxidation function.
3‧‧‧防止穀胱甘肽氧化之包埋結構 3‧‧‧Embedded structure to prevent oxidation of glutathione
31‧‧‧防水層 31‧‧‧Waterproof layer
32‧‧‧蛋白質層 32‧‧‧protein layer
33‧‧‧脂肪層 33‧‧‧Fat layer
34‧‧‧穀胱甘肽粉末核芯 34‧‧‧ glutathione powder core
第1圖為本新型關於一種防止穀胱甘肽氧化之包埋結構之一較佳實施例的側視圖。 BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a side elevational view of a preferred embodiment of an embedding structure for preventing oxidation of glutathione.
請參閱第1圖，本新型係一防止穀胱甘肽氧化之包埋結構所形成之劑體，可供口服使用，並包含一防水層、一蛋白質層、一脂肪層與一穀胱甘肽粉末核芯。 Referring to Fig. 1, the present invention is a dosage form formed by an embedding structure for preventing oxidation of glutathione, which can be used orally and comprises a waterproof layer, a protein layer, a fat layer and a glutathione. Powder core.
防水層可以使用多種脂肪酸成份，厚度範圍介於0.1~10μm。蛋白質層可以使用天然植物蛋白或動物性蛋白，厚度範圍介於0.1~10μm。脂肪層可以使用植物性或動物性脂肪，厚度範圍介於0.1~20μm。 The waterproof layer can be used in a variety of fatty acid compositions ranging in thickness from 0.1 to 10 μm. The protein layer can use natural vegetable protein or animal protein, and the thickness ranges from 0.1 to 10 μm. The fat layer can be used with vegetable or animal fats and has a thickness ranging from 0.1 to 20 μm.
包埋方式可以將穀胱甘肽核芯粉體，使用流動噴霧逐層包埋。 The embedding method can embed glutathione core powder layer by layer using a flow spray.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW107211678U TWM572746U (en) | 2018-08-27 | 2018-08-27 | A coated structure for preventing glutathione oxidation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW107211678U TWM572746U (en) | 2018-08-27 | 2018-08-27 | A coated structure for preventing glutathione oxidation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TWM572746U true TWM572746U (en) | 2019-01-11 |
Family
ID=65805225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW107211678U TWM572746U (en) | 2018-08-27 | 2018-08-27 | A coated structure for preventing glutathione oxidation |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWM572746U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI632891B (en) * | 2016-02-29 | 2018-08-21 | Ｌｇ電子股份有限公司 | Vacuum cleaner |
-
2018
- 2018-08-27 TW TW107211678U patent/TWM572746U/en not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI632891B (en) * | 2016-02-29 | 2018-08-21 | Ｌｇ電子股份有限公司 | Vacuum cleaner |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Atmaca | Antioxidant effects of sulfur-containing amino acids | |
| RU2491062C2 (en) | Compositions of protectors against acute and chronic hepatic encephalopathies and method of treating acute and chronic hepatic encephalopathies | |
| JP2005501061A5 (en) | ||
| JP2007526303A (en) | Solubilized COQ-10 and carnitine | |
| Sakai et al. | Antihypertensive effects of onion on NO synthase inhibitor-induced hypertensive rats and spontaneously hypertensive rats | |
| JP2018012722A5 (en) | ||
| US10272130B1 (en) | Oral anaerobic glutathione supplement in liposome suspension | |
| US20160120817A1 (en) | A process for producing microcapsules comprising an active component encapsulated, protected and stabilised within a protein shell | |
| RU2018145067A (en) | NUTRITIONAL COMPOSITIONS FOR HEART PROTECTION IN ANIMAL COMPANIONS | |
| Mantovani et al. | Cachexia and oxidative stress in cancer: an innovative therapeutic management | |
| CN101325951A (en) | Leucine-rich composition | |
| TWM572746U (en) | A coated structure for preventing glutathione oxidation | |
| Chang et al. | Effect of the protein hydrolysate of rice syrup meal on the endurance exercise performance of BALB/c mice | |
| ES2974661T3 (en) | Blue fish protein hydrolyzate | |
| TWM572747U (en) | A special coated structure of glutathione | |
| Martínez Augustín et al. | Arginina, óxido nítrico y función endotelial | |
| CN108882722A (en) | Release vitamin and mineral on time in edible oil | |
| Kim et al. | Dietary effect of silk protein sericin or fibroin on plasma and epidermal amino acid concentration of NC/Nga mice | |
| ES2329316B1 (en) | OBTAINING AND ANTIHIPERTENSIVE PROPERTIES OF PEPTIDES DERIVED FROM EGG CLEAR PROTEINS. | |
| ES2716278T3 (en) | Products for oral administration comprising extracts of pomegranate Punica granatum, designed for a pet, and applications thereof | |
| Vulcano et al. | Efficacy of free glutathione and niosomal glutathione in the treatment of acetaminophen-induced hepatotoxicity in cats | |
| US20170079311A1 (en) | Method for increasing absorption of plant derived proteins | |
| JP2023108705A (en) | Modified albumin and application thereof | |
| JP2005206528A (en) | Angiotensin converting enzyme inhibitor and food containing the inhibitor | |
| Mahomoodally et al. | Protein hydrolysates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4K | Annulment or lapse of a utility model due to non-payment of fees |